Open access
Open access
Powered by Google Translator Translator

Oncology (all articles)

[Abstract Only] Cost–benefit Analysis of Cancer Drugs in the USA and Europe

14 May, 2020 | 02:25h | UTC

Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries: High cost of cancer drugs not always justified – University of Zurich AND High Cost of Cancer Drugs Does Not Reflect Clinical Benefit – Medscape

 


NCCN Guideline: Hematopoietic Cell Transplantation

10 May, 2020 | 23:53h | UTC

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


ESMO Guidelines: Cancer Patient Management During the Covid-19 Pandemic

5 May, 2020 | 04:41h | UTC

Cancer Patient Management During the Covid-19 Pandemic – European Society of Medical Oncology

Related: NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe AND ASCO Recommendations for the Oncology Community During the COVID19 Pandemic AND COVID-19 rapid guideline: delivery of systemic anticancer treatments – NICE AND COVID-19 rapid guideline: delivery of radiotherapy – NICE AND Caring for patients with cancer in the COVID-19 era – Nature Medicine

 


EULAR Recommendations: Diagnosis and Management of Rheumatic Adverse Events due to Cancer Immunotherapy

5 May, 2020 | 05:18h | UTC

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors – Annals of Rheumatic Diseases

Related: Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy – Rheumatology AND Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature – Current Drug Safety AND Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist – The Journal of Rheumatology AND NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (guidelines and reviews on the subject)

 


Cohort Study: Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer

5 May, 2020 | 04:01h | UTC

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study – European Urology

 


Randomized Trial: Hypofractionated Breast Radiotherapy for 1 Week Noninferior to 3 weeks

30 Apr, 2020 | 04:02h | UTC

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial – The Lancet

Commentaries: 1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? – The Lancet AND One-week course of radiotherapy could benefit women with early stage breast cancer, study finds – Institute of Cancer Research

 


[Abstract Only] Feasibility of Blood Testing Combined with PET-CT to Screen for Cancer and Guide Intervention

30 Apr, 2020 | 04:00h | UTC

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention – Science (link to abstract – $ for full-text)

Commentaries: DNA blood test spots cancers in seemingly cancer-free women, but also produces false alarms – Science AND First study of multicancer blood test to screen for cancer guide intervention – Johns Hopkins Medicine

 


[Abstract Only] Randomized Trial: Olaparib for Metastatic Castration-Resistant Prostate Cancer

30 Apr, 2020 | 03:38h | UTC

Olaparib for Metastatic Castration-Resistant Prostate Cancer – New England Journal of Medicine

 


Patients with Cancer More Vulnerable to SARS-COV-2

29 Apr, 2020 | 05:00h | UTC

Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak – Cancer Discovery

Commentaries: COVID-19 Increases Overall Risk of Death, Complications in Patients With Cancer, Study Shows – AJMC AND Patients with blood and lung cancers are three times more at risk of dying of coronavirus than people with other tumors, study finds – Daily Mail AND Coronavirus: Cancer patients nearly three times more likely to die of Covid-19, study says – Independent

 


ASCO Guideline: Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck

29 Apr, 2020 | 04:43h | UTC

Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline – Journal of Clinical Oncology

 


Study: Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies

24 Apr, 2020 | 03:24h | UTC

Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies – Gastroenterology

Related Study: Another Large Cohort Study Suggests Patients with Low-Risk Adenomas are Not At Increased Risk of Colorectal Cancer (studies on the subject)

 


Meta-Analysis: Interventions for the Management of Malignant Pleural Effusions

23 Apr, 2020 | 09:22h | UTC

Interventions for the management of malignant pleural effusions: a network meta‐analysis – Cochrane Library

 


[Abstract Only] Randomized Trial: Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

23 Apr, 2020 | 09:14h | UTC

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease – New England Journal of Medicine

 


Caring for Patients with Cancer in the COVID-19 Era

17 Apr, 2020 | 02:07h | UTC

Caring for patients with cancer in the COVID-19 era – Nature Medicine

Commentary: Caring for cancer patients in the COVID-19 era – Netherlands Cancer Institute

Related: NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe AND ASCO Recommendations for the Oncology Community During the COVID19 Pandemic AND COVID-19 rapid guideline: delivery of systemic anticancer treatments – NICE AND COVID-19 rapid guideline: delivery of radiotherapy – NICE

 


Meta-Analysis: Aspirin and the Risk of Colorectal and Other Digestive Tract Cancers

17 Apr, 2020 | 01:54h | UTC

Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019 – Annals of Oncology

News Release: Aspirin linked to reduction in risk of several cancers of the digestive tract – European Society of Medical Oncology

 


ASCO Recommendations for the Oncology Community During the COVID19 Pandemic

16 Apr, 2020 | 02:41h | UTC

Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID19 Pandemic – American Society of Medical Oncology

Commentary: ASCO Releases New Guidance on Allocation of Limited Resources in the Oncology Community During COVID-19 Pandemic – The ASCO Post

 


NCCN Guideline: Breast Cancer

16 Apr, 2020 | 02:31h | UTC

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Guidelines for the Management of Hereditary Colorectal Cancer

16 Apr, 2020 | 02:28h | UTC

Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) – Gut

 


NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe

10 Apr, 2020 | 03:17h | UTC

Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe – Journal of the National Comprehensive Cancer Network

News Release: JNCCN: Improving COVID-19 safety for cancer patients and healthcare providers – National Comprehensive Cancer Network

 


ASCO Guideline: Management of Hereditary Breast Cancer

7 Apr, 2020 | 04:09h | UTC

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline – Journal of Clinical Oncology

 


ASCO Guideline: Systemic Therapy for Melanoma

3 Apr, 2020 | 03:57h | UTC

Systemic Therapy for Melanoma: ASCO Guideline – Journal of Clinical Oncology

 


Study Evaluates Sensitivity and Specificity of New Multi-Cancer Detection Test

2 Apr, 2020 | 03:56h | UTC

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA – Annals of Oncology

 


The Lancet Commission: Sustainable Care for Children with Cancer

1 Apr, 2020 | 05:37h | UTC

Sustainable care for children with cancer – The Lancet Oncology (free articles – registration required)

 


A War on Two Fronts: Cancer Care in the Time of COVID-19

30 Mar, 2020 | 01:51h | UTC

A War on Two Fronts: Cancer Care in the Time of COVID-19 – Annals of Internal Medicine

Related Guidelines: COVID-19 rapid guideline: delivery of systemic anticancer treatments – National Institute for Health and Care Excellence AND Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal – Journal of the National Comprehensive Cancer Network

 


#ACC20 – [Abstract Only] Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

30 Mar, 2020 | 01:12h | UTC

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer – New England Journal of Medicine (abstract Only – $ for full-text)

Commentaries: Caravaggio Trial: Apixaban Noninferior to Dalteparin in Treatment of Cancer-Associated VTE – American College of Cardiology (free) AND Apixaban, Dalteprin Shown to Have Same Bleeding Risk in Patients With Cancer – AJMC (free)

Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.